Telomere Length is a Novel Predictive Biomarker of Sensitivity to Anti-EGFR Therapy in Metastatic Colorectal Cancer

T A Augustine; M Baig; A Sood; T Budagov; G Atzmon; J M Mariadason; S Aparo; R Maitra; S Goel

doi:10.1038/bjc.2014.561

Telomere Length is a Novel Predictive Biomarker of Sensitivity to Anti-EGFR Therapy in Metastatic Colorectal Cancer

T A Augustine, M Baig, A Sood, T Budagov, G Atzmon, J M Mariadason, S Aparo, R Maitra, S Goel

Miami Cancer Institute

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	British Journal of Cancer
Volume	112
DOIs	https://doi.org/10.1038/bjc.2014.561
State	Published - Jan 20 2015

Disciplines

Medicine and Health Sciences
Pathology

Access to Document

10.1038/bjc.2014.561License: Unspecified

Cite this

@article{68c1a0aedeaa409692432ab2c30ad83c,

title = "Telomere Length is a Novel Predictive Biomarker of Sensitivity to Anti-EGFR Therapy in Metastatic Colorectal Cancer",

author = "Augustine, \{T A\} and M Baig and A Sood and T Budagov and G Atzmon and Mariadason, \{J M\} and S Aparo and R Maitra and S Goel",

note = "Telomere length could be a potential unique biomarker predictive of clinical benefit (PFS) of mCRC patients treated with anti-EGFR therapy. This is the novel demonstration of a complex hitherto undescribed interaction, placing anti-EGFR therapy, EGFR pathway, and the telomerase complex within a clin ...",

year = "2015",

month = jan,

day = "20",

doi = "10.1038/bjc.2014.561",

language = "American English",

volume = "112",

journal = "British Journal of Cancer",

}

TY - JOUR

T1 - Telomere Length is a Novel Predictive Biomarker of Sensitivity to Anti-EGFR Therapy in Metastatic Colorectal Cancer

AU - Augustine, T A

AU - Baig, M

AU - Sood, A

AU - Budagov, T

AU - Atzmon, G

AU - Mariadason, J M

AU - Aparo, S

AU - Maitra, R

AU - Goel, S

N1 - Telomere length could be a potential unique biomarker predictive of clinical benefit (PFS) of mCRC patients treated with anti-EGFR therapy. This is the novel demonstration of a complex hitherto undescribed interaction, placing anti-EGFR therapy, EGFR pathway, and the telomerase complex within a clin ...

PY - 2015/1/20

Y1 - 2015/1/20

UR - https://pubmed.ncbi.nlm.nih.gov/25412235/

U2 - 10.1038/bjc.2014.561

DO - 10.1038/bjc.2014.561

M3 - Article

VL - 112

JO - British Journal of Cancer

JF - British Journal of Cancer

ER -

Telomere Length is a Novel Predictive Biomarker of Sensitivity to Anti-EGFR Therapy in Metastatic Colorectal Cancer

Disciplines

Access to Document

Other files and links

Cite this